U.S. stocks on the move: Veracyte, Staar Surgical, Corning
VCYT•Veracyte gained on data supporting its prostate cancer test’s use in treatment decisions, Staar Surgical rose after a Stifel upgrade to buy, and Corning rose on an agreement with AT&T valued at more than $3 billion.
1. Veracyte test data
Veracyte shares gained on data supporting the use of its prostate cancer test to guide treatment decisions.
2. Staar upgrade
Staar Surgical shares rose after Stifel upgraded the company to buy.
3. Corning agreement
Corning shares rose on an agreement with AT&T valued at more than $3 billion.
